Avid Bioservices Welcomes New Leader for Technology and Transformation
The newly created role marks a major step in CEO Kenneth Bilenberg's vision to scale Avid for its next chapter of growth.
Avid Bioservices, Inc., a leading biologics contract development and manufacturing organization (CDMO), has announced the appointment of Dave Stewart as Chief Technology and Transformation Officer. This role is pivotal to advancing the company's growth and evolution strategy.
This significant addition to the leadership team highlights the commitment of CEO Kenneth Bilenberg to position Avid for continued expansion and to ensure it remains a trusted partner for clients, characterized by reliability and proactivity.
Strategic Focus on Future Growth
According to Bilenberg, "Avid has built tremendous momentum over the past several years. Looking ahead, we are intentionally investing in people, processes, and systems to secure our future success. With Dave designated for this key leadership position, we are confident in the depth of expertise and integrity he brings to our team." His leadership is essential to maintaining Avid's vision to be the easiest external partner to collaborate with.
Leading Innovations at Avid
In his role, Stewart will spearhead efforts in technology integration and process transformation throughout Avid's development and manufacturing network. His initiatives will encompass digital modernization, automation efforts, and the integration of advanced tools and services that enhance operational capability.
Stewart expressed enthusiasm about joining Avid, stating, "I've long admired Avid's reputation for quality and its unwavering focus on patients. The staff here is dedicated to excellence, and this commitment is reflected in all their efforts. Being part of this team during a pivotal growth phase is a significant opportunity, allowing me to contribute to a mission I truly believe in."
Commitment to Continuous Improvement
The establishment of the Chief Technology and Transformation Officer role embodies Avid's dedication to continuous improvement, ensuring that the company remains agile and ready for the future. As it expands its capacity and capabilities across its facilities, Avid aims to solidify its status as a preferred partner across the biopharmaceutical landscape.
About Avid Bioservices
Avid Bioservices stands as a global leader in contract development and manufacturing services, specializing in mammalian cell-culture manufacturing. With a solid FDA record, Avid is trusted by biopharmaceutical innovators worldwide, known for its agility and quality in navigating complex global regulatory environments. The organization is experienced in providing end-to-end solutions tailored for emerging biotech firms and large international pharmaceutical companies.
Avid's Accomplishments
Avid's proficiency can be quantified by several milestones:
- Manufactured over 600 batches:
- Delivered more than 275 commercial batches globally:
- Successfully launched 6+ commercial products:
- Completed 10 pre-approval inspections across major regulatory authorities:
Frequently Asked Questions
Who is Dave Stewart?
Dave Stewart is the newly appointed Chief Technology and Transformation Officer at Avid Bioservices, responsible for leading technological advancements within the organization.
What is the primary focus of Avid under Stewart's leadership?
The primary focus will be on technology integration, processes, and modernizing systems to enhance efficiency and support Avid's growth trajectory.
What kind of company is Avid Bioservices?
Avid Bioservices is a contract development and manufacturing organization (CDMO) that specializes in biopharmaceutical production, particularly mammalian cell-culture systems.
Which industries does Avid serve?
Avid serves a range of industries, including emerging biotech and large multinational pharmaceutical companies.
What is Avid's commitment to quality?
Avid is dedicated to maintaining high standards in quality and compliance, reflected in its flawless FDA record and focus on patient care.
